Richard U. de Schutter, Director at Valeant Pharmaceuticals International, Inc. (VRX), bought 10,000 shares at $14.35 ($143K) on 2017-08-21, disclosed to the SEC on 2017-08-22.
Open-market purchase of $143k VRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.31 | 5,100 | $73K | 50.9% |
| 2 | $14.35 | 4,900 | $70K | 49.1% |
| Total | $14.33 avg | 10,000 | $143K | 100% |
| Filing → |
| BHC | BUY | 2018-09-17 | $3.0M | — | Filing → |
| VRX | BUY | 2018-07-03 | $218K | — | Filing → |
| VRX | BUY | 2018-05-17 | $327K | — | Filing → |